[1]馮 鸞,高曉潔.分化型甲狀腺癌術后行131Ⅰ治療患者自我管理效能與生命質量的相關性分析[J].醫學信息,2020,(04):184-187.[doi:10.3969/j.issn.1006-1959.2020.04.063]
 FENG Luan,GAO Xiao-jie.Correlation Between Self-management Efficacy and Quality of Life in Patients with Differentiated Thyroid Cancer Undergoing 131Ⅰ[J].Medical Information,2020,(04):184-187.[doi:10.3969/j.issn.1006-1959.2020.04.063]
點擊復制

分化型甲狀腺癌術后行131Ⅰ治療患者自我管理效能與生命質量的相關性分析()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2020年04期
頁碼:
184-187
欄目:
護理研究
出版日期:
2020-02-15

文章信息/Info

Title:
Correlation Between Self-management Efficacy and Quality of Life in Patients with Differentiated Thyroid Cancer Undergoing 131Ⅰ
文章編號:
1006-1959(2020)04-0184-04
作者:
馮 鸞高曉潔
(南京醫科大學附屬南京醫院/南京市第一醫院核醫學科,江蘇 南京 210006)
Author(s):
FENG LuanGAO Xiao-jie
(Department of Nuclear Medicine,Nanjing Hospital of Nanjing Medical University/Nanjing First Hospital,Nanjing 210006,Jiangsu,China)
關鍵詞:
甲狀腺癌放射性碘治療自我管理生命質量相關性分析
Keywords:
Thyroid cancerRadioactive iodine therapySelf-managementQuality of lifeCorrelation analysis
分類號:
R473.73;R736.1
DOI:
10.3969/j.issn.1006-1959.2020.04.063
文獻標志碼:
A
摘要:
目的 調查分化型甲狀腺癌術后行放射性131Ⅰ治療患者自我效能水平與生命質量現狀,分析患者自我管理效能與生命質量的相關性。方法 采用方便抽樣方法,選取2016年1月~2017年12月于南京市第一醫院核醫學科住院的215例甲狀腺癌術后行放射性131Ⅰ治療患者進行問卷調查,問卷包括自行設計的一般資料調查表、健康促進策略量表和癌癥生命質量核心量表,記錄患者自我效能得分及生活質量得分,Person相關性分析自我管理效能與生命質量的關系。結果 共發放調查問卷215份,回收215份,有效問卷200份,有效率為93.02%。分化型甲狀腺癌術后行放射性131Ⅰ治療患者的自我管理效能總分為(89.72±19.72)分,中等水平和高等水平比例分別為82.42%和15.31%,各維度得分由高到低分別為正性態度得分(48.28±9.27)分、自我減壓得分(31.87±7.96)、自我決策得分(9.57±2.49);颊呱|量總分為(59.04±10.17)分,功能領域中得分最低的是社會功能維度,癥狀領域得分最高的是疲倦維度,單項條目得分最高的是經濟困難維度。Pearson相關性分析顯示,生命質量中功能領域各維度和總體健康狀況與自我管理效能總分及各維度呈正相關(P<0.05),生命質量中癥狀領域、單項條目各維度與自我管理效能總得分及各維度呈負相關(P<0.05)。結論 甲狀腺癌術后行放射性131Ⅰ治療患者的自我管理效能處于中等水平,自我管理效能與生命質量中功能領域存在正性影響,與癥狀領域存在負性影響。
Abstract:
Objective To investigate the status of self-efficacy and quality of life in patients with differentiated thyroid cancer undergoing radioactive 131Ⅰ surgery, and to analyze the correlation between self-efficacy and quality of life in patients. Methods A convenient sampling method was used. A questionnaire survey was conducted on 215 patients who underwent radioactive 131Ⅰ treatment for thyroid cancer after surgery in the Department of Nuclear Medicine of Nanjing First Hospital from January 2016 to December 2017. The questionnaire included self-designed general data Tables, health promotion strategy scale and core quality of life scale for cancer, recorded patients’ self-efficacy scores and quality of life scores, and Person correlation analysis of the relationship between self-management efficacy and quality of life. Results A total of 215 questionnaires were distributed, the return of 215 respondents, 200 copies were valid, and the effective rate was 93.02%. The self-management efficacy of patients with differentiated thyroid cancer who underwent radioactive 131Ⅰ treatment was (89.72±19.72) score, and the proportions of intermediate and advanced levels were 82.42% and 15.31%, respectively; the scores of each dimension from high to low were positive attitude (48.28±9.27)score, self decompression (31.87±7.96) score, and self decision (9.57±2.49)score. The overall health score of the patient was (59.04±10.17) score. The lowest score in the functional area was the social function dimension, the highest score in the symptom field was the fatigue dimension, and the highest score in the single item was the economic difficulty dimension. Pearson correlation analysis showed that the dimensions of functional areas and overall health status in quality of life were positively correlated with the total score and dimensions of self-management efficacy (P<0.05), while the dimensions of symptom areas and individual items in quality of life were negatively correlated with the total score and dimensions of self-management efficacy (P<0.05).Conclusion The self-management efficacy of patients undergoing radioactive 131Ⅰ treatment for thyroid cancer after surgery is at a medium level. The self-management efficacy and the functional area of quality of life are positively affected and negatively affected by the symptoms area.

參考文獻/References:

[1]蔣婷,汪君如,張瑋,等.分化型甲狀腺癌患者術后碘131治療的不良反應護理[J].華西醫學,2016(4):747-749. [2]張鑫,王宸,梁軍,等.進展性碘難治性分化型甲狀腺癌患者阿帕替尼治療后血清學與影像學指標變化[J].中國腫瘤臨床,2017,44(8):371-376. [3]陳萍,李健君,王耀宗,等.自我管理效能感對甲狀腺癌術后替代療法服藥依從性的影響[J].中華內分泌外科雜志,2017,11(3):220-223. [4]周英華,錢會娟,袁長蓉.中文版癌癥自我管理效能量表在肺癌人群中的信、效度研究[J].解放軍護理雜志,2013,30(7):31-33. [5]王婷,任艷軍,孔靜霞,等.甲狀腺癌患者生命質量的測定量表及應用[J].中華內分泌代謝雜志,2015,31(12):1074-1076. [6]關思源.放射性碘治療對甲狀腺癌全切術后患者生命質量的影響[J].中國醫藥科學,2017,7(5):146-148. [7]楊俊華,張敏,張文林,等.激勵式護理對甲狀腺癌手術患者負性情緒及生存質量的影響[J].中華現代護理雜志,2016,22(23):3330-3333. [8]孫廣榮,鄒萍,韓甜.循證護理對提高普外手術病人認知能力及滿意度的影響[J].循證護理,2017,3(3):286-288. [9]陳玉梅,趙麗麗,閆樹英,等.胃腸道惡性腫瘤患者自我效能感的現狀及影響因素分析[J].寧夏醫學雜志,2015,37(6):550-552. [10]張瑋,孫俐,王欣,等.甲狀腺癌術后患者病恥感與生命質量的相關性[J].實用醫學雜志,2017(22):3822-3825. [11]周鑫,楊小平,何怡,等.常州市金壇區2003~2014年甲狀腺癌患者生存狀況及其影響因素[J].中國慢性病預防與控制,2017(1):9-12. [12]杭家伊,王兆霞.甲狀腺癌術后患者自我管理效能水平及影響因素分析[J].中國耳鼻咽喉頭頸外科,2017,24(2):67-70. [13]余偉冰,吳春鳳.規范化護理對癌痛患者提高生活質量增強自我管理效能的作用[J].中國當代醫藥,2016,23(29):179-181. [14]沈玉蓉.自我管理對婦科惡性腫瘤患者生活質量及心理狀況的影響[J].中國臨床護理,2016,8(4):338-340.

相似文獻/References:

[1]李 焰,蒲玉平,鄭 軻,等.甲狀腺癌術后不同時間拔除引流條的效果分析[J].醫學信息,2019,(04):116.[doi:10.3969/j.issn.1006-1959.2019.04.037]
 LI Yan,PU Yu-ping,ZHENG Ke,et al.Analysis of the Effect of Removing Drainage Strips at Different Times after Thyroid Cancer Operation[J].Medical Information,2019,(04):116.[doi:10.3969/j.issn.1006-1959.2019.04.037]
[2]孫 陽.甲狀腺結節鈣化在超聲診斷甲狀腺癌中的價值[J].醫學信息,2019,(24):173.[doi:10.3969/j.issn.1006-1959.2019.24.064]
 SUN Yang.The Value of Thyroid Nodule Calcification in Ultrasound Diagnosis of Thyroid Cancer[J].Medical Information,2019,(04):173.[doi:10.3969/j.issn.1006-1959.2019.24.064]
[3]黃琪峰,鄭琳琳,張 菁.甲狀腺癌中miR-222關鍵靶基因預測及其信號通路分析[J].醫學信息,2020,(01):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
 HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Prediction of Key Target Genes of miR-222 in Thyroid Cancer and Analysis of Its Signal Pathway[J].Medical Information,2020,(04):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
[4]李婷婷,李素梅,許琳琳.甲狀腺癌流行病學分析及超聲診斷價值[J].醫學信息,2020,(05):85.[doi:10.3969/j.issn.1006-1959.2020.05.025]
 LI Ting-ting,LI Su-mei,XU Lin-lin.Epidemiological Analysis and Diagnostic Value of Thyroid Cancer[J].Medical Information,2020,(04):85.[doi:10.3969/j.issn.1006-1959.2020.05.025]

更新日期/Last Update: 2020-02-15
中国足彩网竞彩 短期理财平台 南粤风采36选7 吉林体彩11选5最大遗漏 多乐彩历史开奖号码 甘肃快3开奖一500彩票 股票分析师介绍 澳洲幸运5官网走势app 10分快3是真的吗 炒股网上开户靠不靠谱 福彩快乐12开奖查询